TrialClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2015

A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma.

J M Sepúlveda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.